Afleveringen
-
Matthew Dunehoo and David delve into an enlightening discussion about the hurdles, victories, and breakthroughs propelling PSYC ahead. They explore how Psychedelic Spotlight is adapting to changes and what these developments signify for stakeholders and the broader community, reaffirming their dedication to advancing psychedelic medicine.
-
Host David Flores welcomes Dr. Steven L. Mandel, President and Founder of Ketamine Clinics Los Angeles, to shed light on the misconceptions and stigmas associated with ketamine therapy. They tackle the widespread misinterpretations of Perry’s autopsy report and its unintended consequences on the public's understanding of ketamine's role in treating mood disorders. Dr. Mandel elucidates the stark difference between the recreational abuse of substances like ketamine and their controlled, therapeutic use, drawing an analogy with alcohol consumption to clarify this distinction. Throughout the episode, they explore various aspects of ketamine therapy, discussing its effectiveness, the risks associated with recreational use, and its application in addiction treatment. Insights into the high standards maintained in ketamine clinics and the impactful patient stories further illuminate the significant, life-changing breakthroughs achieved through this treatment, often in combination with psychotherapy. This enlightening conversation aims to dispel myths and educate listeners on the safe and responsible use of psychedelics like ketamine in medical settings, emphasizing their transformative potential when used correctly.
-
Zijn er afleveringen die ontbreken?
-
Host, David Flores, is joined by Joseph Caltabiano, the newly appointed Chairman and CEO of The Healing Realty Trust ("The HRT"), and Cody Shandraw, President and Founder of The HRT for an enlightening discussion on the critical role real estate is expected to play in helping to establish the clinical infrastructure necessary to support the effective rollout of psychedelic-assisted therapy in the months and years ahead.
-
Riley and David chat about "Peace of Mind," the ESPN documentary that premiered this spring highlighting the role psychedelic therapy has played in the healing journeys of retired professional athletes like Riley who spent several years participating in physically violent sports like hockey, football, and boxing. They also take a deep dive into the debated, and at times, controversial, topic related to the important role spirituality plays in the psychedelic healing experience.
-
Kevin Colley, a former professional hockey player with over a decade of experience, including a stint with the NHL's New York Islanders, embarked on a profound journey earlier this year. Invited by fellow retired NHL player Riley Cote, Kevin participated in a transformative psychedelic-focused retreat as a patient of WAKE's clinical program in Jamaica. This experience allowed him to shed years of emotional and physical trauma stemming from a devastating neck injury in January 2006 that prematurely ended his hockey career and plunged him into a dark and seemingly hopeless period of his life.
Our conversation also delves into the concept of male masculinity, particularly in individuals like Kevin who spent their lives in physically demanding and "tough guy" sports such as hockey. Kevin's story highlights the importance of finding the courage to seek help when needed. It's yet another inspirational tale of healing and discovering one's true self through the transformative power of psychedelic-assisted therapy.
-
Hadas provides insights into her role at APPA and the organization's mission to seamlessly integrate psychedelic medicine into the U.S. healthcare system.
We also dive into the significance of the first-ever professional practice guidelines for psychedelic-assisted therapy co-published by APPA and BrainFutures. These guidelines are shaping the future of psychedelic therapy and ensuring its safety and effectiveness.
Additionally, we discuss APPA's strategic partnership with The Daschle Group and its role in advancing the implementation of psychedelic-assisted therapy within the healthcare system.
Join us for a captivating conversation about the transformative potential of psychedelics in healthcare and the vital work being done by APPA to make it a reality.
-
This revolutionary service is designed to cater to individuals who find themselves in the midst of a psychedelic experience or in need of vital integration support.
The Fireside Project is a shining beacon in the expanding landscape of psychedelic research and advocacy. It stands as a testament to the growing recognition of the importance of providing compassionate and informed assistance to those who choose to explore the profound realms of psychedelics outside of clinical settings. Joshua White's leadership in spearheading this initiative underscores the urgency and significance of creating a safe space for individuals to turn to during their psychedelic journeys.
One of the key points of discussion in this episode is the critical role of a helpline specifically tailored for nonclinical psychedelic users. With the resurgence of interest in psychedelics as a therapeutic tool, many individuals are embarking on personal journeys without the guidance of medical professionals. This reality emphasizes the need for accessible and empathetic support, ensuring that anyone who chooses to explore these substances can do so with a sense of security and trust in the process.
To learn more about Fireside, visit: firesideproject.org.
-
Reason for Hope is a national non-profit organization with a focus on advocating for policy and legal reforms to make safe, ethical, and affordable access to psychedelic-assisted therapy a reality.
Brett Waters shares his personal motivation behind founding Reason for Hope after the tragic loss of his mother to suicide in 2018. He discusses his role in drafting psychedelic legislation in multiple states, including Connecticut, Pennsylvania, and New York, and his involvement in briefings for the White House Domestic Policy Council, HHS, and members of Congress regarding the importance of an inter-agency psychedelic task force.
The conversation dives into Reason for Hope's mission to prevent deaths of despair by promoting accessible psychedelic medicine and assisted therapies. They support the bipartisan Breakthrough Therapies Act, aimed at expediting research and deployment of psychedelic therapies with breakthrough status.
Brett also introduces the collaborative efforts of Reason for Hope's team, which includes strategic minds from various fields, working together in drafting legislation, preparing legal briefings, educating legislators, and building advocacy coalitions. Currently, Reason for Hope focuses on establishing MDMA- and psilocybin-assisted therapy expanded access pilot programs for those unable to wait for FDA approval.
Tune in to explore the inspiring work of Reason for Hope and Brett's personal journey driving legislative change for psychedelic therapies. Subscribe to the Psychedelic Spotlight podcast for more insightful conversations and stay connected with Psychedelic Spotlight on your favorite social media platforms.
Find out more about Reason for Hope here: https://www.reason-for-hope.org/
-
Charles Lazarus, Chief Cultivation and Production Officer, and Kevin Bourke, Chief Marketing and Branding Officer, share insights with us into Rose Hill's three channels of business units:
Rose Hill: The historic Rose Hill Estate has transformed into a hub for cultivating organic produce and functional and psychedelic mushrooms, showcasing sustainable practices and research collaborations.
PATOO: As the world's first legal psilocybin brand, PATOO offers an array of products, including capsules, honey, chocolate bars, and gummies, all infused with psilocybin.
ONE Psilocybin Retreats: An upcoming venture that provides immersive psilocybin retreat experiences in Jamaica, designed in partnership with veterans.
Our guests also discuss Rose Hill's innovative collaborations in genetics and substrates, their role in pioneering research on PTSD and depression, and their commitment to accessible, sustainable, and responsible use of psilocybin. Join us as we dive into the intriguing world of psilocybin innovation with Rose Hill's visionary leaders.
For more information on Rose Hill, please visit: https://rosehill.life/science/
-
Most of us have probably heard some version of the saying “a happy and healthy employee is a productive employee”. But requesting a meeting with your company’s HR representative or CEO to discuss ketamine assisted therapy might feel like something that could get you fired from your job given the long-standing and ill-advised stigma that remains tied to many psychedelic and dissociative medicines like ketamine.
This is exactly where Enthea is focused on bridging the divide between employers and legal access to psychedelic-assisted therapies within the workplace. Enthea is a mental health company dedicated to providing access to safe and affordable psychedelic-assisted therapy, beginning with ketamine therapy.
Listen to this week's episode of the Psychedelic Spotlight Podcast to learn about Enthea and their goal to make psychedelics more accessible and affordable to everyone!
To learn more about Enthea, visit their website at https://www.enthea.com/ and https://www.enthea.net/
-
Mushrooms Inc. is the first company trading on the US stock market focused on the industrial side of mushrooms under the ticker MSRM (OTC: MSRM). They are part of a worldwide expansion into regenerative agriculture focused on the mushroom industry.
Their Research and Development is focused on bringing the science of mycology to the forefront of manufacturing by replacing toxic plastics, packaging, and improving medical threads and fabrics.
Mycelium are the root-like structure of a fungus consisting of a mass of branching, thread-like hyphae. These can be used in turn to manufacture biodegradable, sustainable materials such as bricks, packaging, medical gauze, and textiles.
In this episode, David and Kimberly talk about the mission of Mushrooms, Inc. and the plans the company has for the future.
This is an episode you do not want to miss out!
You can find out more information on Mushrooms Inc. by visiting www.mushroomsinc.com
-
Stephanie discusses her mission to assist people in discovering inner peace and emotional wellness through Kanna, as well as her inspiring journey and motivations. She shares her own struggle with depression and how using the plant helped her experience transformative results.
According to Stephanie, consuming one KA! chew per day can help minimize stress levels and enhance intimacy with your partner. It may also assist in reducing food cravings.
You can find more information about KA! Empathogenics here.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. -
Paul has decades of experience in the world of psychedelics. In the 1960’s he was a member of the early psychedelic communities in New York and California, which included such luminaries as Timothy Leary and Ram Dass. Paul co-founded Thompson’s Ranch, one of the first alternative communities in Joshua Tree, CA.
Matthew and Paul discuss The Psychedelic Institute’s aspirations with the newest iteration of the Awakening of Consciousness Conference, the power of connection and community, how to create community, and talk about how healing looks like for people and how psychedelics can help facilitate this.
To learn more about the Awakening 2023 conference, visit: https://psychedelic-awakening.com/
To learn more about the work of The Psychedelic Institute, visit: https://www.psychedelicinstitute.org/
-
Brayden shares his thoughts on how The BC Bud Co is carving out a unique identity for the company in an increasingly competitive marketplace by leaning fully into a business model that does not include farming and producing their own product – a true rarity for a cannabis focused company.
He also explains how the company’s decision to adopt and fully embrace a marathon versus sprint model has helped place them into a position to capitalize on a market sector that has seen its fair share of casualties over the past few years.
This is truly a wonderful and informative conversation that anyone following the cannabis market sector will not want to miss. So sit back and enjoy the show.
The Company trades on the OTC Markets under the symbol $BCBCF and you can find more information about them by visiting their website at https://www.thebcbc.com/
-
Conference season for the psychedelics sector is beginning to ramp up and today we have the pleasure of spotlighting the PhilaDelic Conference 2023 which will take place at the University of Pennsylvania on July 13th – 15th.
Joining us to share details surrounding PhilaDelic is Victor Acero. Victor is a University of Pennsylvania PHD Candidate, Chair of Graduate Advisory Board for Penn Psychedelics Collaborative, Co-Founder and Director of Internal Operations for the Intercollegiate Psychedelics Network and Co-Organizer for the PhilaDelic Conference 2023.
Listeners of the Psychedelic Spotlight podcast are eligible to receive an exclusive 20% discount off tickets to PhilaDelic simply by using the code “Spotlight” at checkout.
Visit PhilaDelic.org for more information!
Stay in touch with them on Instagram at @pennphiladelic
-
John Wood is the founder of Rageheart, an online program that teaches people how to navigate and integrate their psychedelic journeys without traditional tools like meditation, breathwork, or $49 Moleskin journals. He developed a practice that couples perfectly with the use of psychedelics and moves stored trauma out of the body by teaching people how to get out of their head and into their body. Out of thinking and into feeling.
You can learn more about John and Rageheart over at: https://www.rageheart.co/
-
Matthew Weintrub is a healer, psychedelic activist, scholar, entrepreneur, and author of the book "The Psychedelic Origin of Religion," an exploration of the common heritage of psychedelics and shamanism in all world religions. Drawing on extensive research and personal experience, Matthew details how the use of psychedelics in spiritual rituals can be traced back to the earliest human societies.
You can purchase his book over on Amazon: https://www.amazon.com/Psychedelic-Religion-Matthew-Lawrence-Weintrub-ebook/dp/B0BRYN78Z4
Follow Matthew on Instagram over at: https://www.instagram.com/heytrub/
-
Dr. Sam Zand and Derek Du Chesne are Co-Founders of Better U, a ketamine therapy clinic that has built a robust psychedelic ecosystem focused on helping people elevate their mental health. From their work with high-performance professional athletes and corporate executives looking for an edge, to their relationships within the entertainment industry, Better U is helping to bring a new level of awareness to mental health on the world stage.
-
The concept of a five-star retreat center is certainly anything new or groundbreaking. But what about the concept of a five-star retreat center that incorporates psychedelics and other plant-based healing modalities into it in a setting that is every bit welcoming, luxurious, safe and responsible? Enter Dimensions Retreats, a psychedelic retreat center that is aiming to taking retreats to a whole new level.
Dimensions Retreats is a psychedelic retreat whose approach combines the insights of Western science with the ancient traditions of plant medicine to create a new paradigm for mental health treatment, improved consciousness and self-betterment.
You can learn more about their services and missions over at dimensionsretreats.com, and stay in touch with them on social media over on Instagram (@dimensionsretreats) or Twitter (@dimensionsreset).
-
Manesh Girn is a psychedelic neuroscientist firmly rooted in both academia and industry. He joins us on the Psychedelic Spotlight podcast today to speak about his research into neuroimaging of the brain while subjected to psychedelic states, as well as to speak about the nuances of biotech companies seeking to monopolize certain compounds. We discuss the merit of whether or not psychedelic researchers should have subjective experiences with the compounds they’re researching, and hear about the blindspots in the psychedelic research community.
You can keep in touch with Manesh over on:
Twitter: @mgirnneuro
Instagram: @maneshgirn
And check out his relevant links on Link Tree: https://linktr.ee/thepsychedelicscientist - Laat meer zien
